BI 764524

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 764524, covering 2024-05-22 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy [Phase 2]